We are writing on behalf of the 2.21% of Americans with autism to request approval and insurance coverage for Stem Cell Therapy (SCT) in the United States. Countries like Panama and Mexico have successfully used SCT to treat autism for years, but Americans face price gouging due to FDA approval delays. Clinical trials have stalled at Phase 2. Research shows 85% of ASD patients respond to simple mesenchymal stem cell infusions with significant improvements in calmness, sleep, and verbalization. Current therapies like ABA, Occupational, and Speech Therapy are insufficient for true healing. We urge you to empower parents with access to SCT and insurance coverage, giving hope to those who desperately need it.
With unwavering love and patriotism,
The Deritis family